AU574926B2 – Anti-cancer treatment using imidazolyl or pyridyl alkoxyphenoxydimethylalkanoates
– Google Patents
AU574926B2 – Anti-cancer treatment using imidazolyl or pyridyl alkoxyphenoxydimethylalkanoates
– Google Patents
Anti-cancer treatment using imidazolyl or pyridyl alkoxyphenoxydimethylalkanoates
Info
Publication number
AU574926B2
AU574926B2
AU59305/86A
AU5930586A
AU574926B2
AU 574926 B2
AU574926 B2
AU 574926B2
AU 59305/86 A
AU59305/86 A
AU 59305/86A
AU 5930586 A
AU5930586 A
AU 5930586A
AU 574926 B2
AU574926 B2
AU 574926B2
Authority
AU
Australia
Prior art keywords
alkoxyphenoxydimethylalkanoates
imidazolyl
pyridyl
cancer treatment
cancer
Prior art date
1985-06-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59305/86A
Other versions
AU5930586A
(en
Inventor
Yoso Numasaki
Isao Ohata
Koichiro Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1985-06-26
Filing date
1986-06-26
Publication date
1988-07-14
1986-06-26
Application filed by Yamanouchi Pharmaceutical Co Ltd
filed
Critical
Yamanouchi Pharmaceutical Co Ltd
1987-01-08
Publication of AU5930586A
publication
Critical
patent/AU5930586A/en
1988-07-14
Application granted
granted
Critical
1988-07-14
Publication of AU574926B2
publication
Critical
patent/AU574926B2/en
2006-06-26
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D213/62—Oxygen or sulfur atoms
C07D213/63—One oxygen atom
C07D213/64—One oxygen atom attached in position 2 or 6
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
A61K31/415—1,2-Diazoles
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00—Antineoplastic agents
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D213/62—Oxygen or sulfur atoms
C07D213/63—One oxygen atom
C07D213/65—One oxygen atom attached in position 3 or 5
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
AU59305/86A
1985-06-26
1986-06-26
Anti-cancer treatment using imidazolyl or pyridyl alkoxyphenoxydimethylalkanoates
Ceased
AU574926B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
JP60-140901
1985-06-26
JP14090185
1985-06-26
Publications (2)
Publication Number
Publication Date
AU5930586A
AU5930586A
(en)
1987-01-08
AU574926B2
true
AU574926B2
(en)
1988-07-14
Family
ID=15279431
Family Applications (2)
Application Number
Title
Priority Date
Filing Date
AU59128/86A
Withdrawn
AU5912886A
(en)
1985-06-26
1986-06-20
Tumor treatment in warm-blooded animals
AU59305/86A
Ceased
AU574926B2
(en)
1985-06-26
1986-06-26
Anti-cancer treatment using imidazolyl or pyridyl alkoxyphenoxydimethylalkanoates
Family Applications Before (1)
Application Number
Title
Priority Date
Filing Date
AU59128/86A
Withdrawn
AU5912886A
(en)
1985-06-26
1986-06-20
Tumor treatment in warm-blooded animals
Country Status (4)
Country
Link
US
(2)
US4758580A
(en)
EP
(1)
EP0210753A3
(en)
JP
(1)
JPS6289618A
(en)
AU
(2)
AU5912886A
(en)
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU604034B2
(en)
*
1986-07-24
1990-12-06
Yamanouchi Pharmaceutical Co., Ltd.
Novel phenoxy derivatives, their preparation and pharmaceutical composition containing them
Families Citing this family (11)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4758580A
(en)
*
1985-06-26
1988-07-19
Yamanouchi Pharmaceutical Co., Ltd.
Inhibiting growth of tumors with certain substituted phenoxy dimethyl alkanoic acids, esters or salts
US5389366A
(en)
*
1986-09-19
1995-02-14
Yamanouchi Pharmaceutical Co., Ltd.
Neocarzinostatin derivative composition for oral administration
US4851423A
(en)
*
1986-12-10
1989-07-25
Schering Corporation
Pharmaceutically active compounds
US5750532A
(en)
*
1986-12-10
1998-05-12
Schering Corporation
Pharmaceutically active compounds
WO1991000858A1
(en)
*
1989-07-07
1991-01-24
Schering Corporation
Pharmaceutically active compounds
US5633274A
(en)
*
1993-02-18
1997-05-27
President And Fellows Of Harvard College
Cancer treatments
US5512591A
(en)
*
1993-02-18
1996-04-30
President And Fellows Of Harvard College
Treatments for diseases characterized by neovascularization
US5556871A
(en)
*
1995-04-24
1996-09-17
President & Fellows Of Harvard College
Method for treating epithelial precancerous lesions with topical inidazoles
EP0986393B1
(en)
*
1997-05-27
2004-03-24
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
JP4912875B2
(en)
*
2004-02-27
2012-04-11
不二製油株式会社
Composition for inhibiting cancer metastasis
AU2008263931A1
(en)
*
2007-06-13
2008-12-18
Ge Healthcare Bio-Sciences Corp
Polymerase stabilization
Family Cites Families (4)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
JPS5951943B2
(en)
*
1978-08-21
1984-12-17
キツセイ薬品工業株式会社
Novel imidazole derivative
ES533668A0
(en)
*
1983-06-24
1985-10-01
Yamanouchi Pharma Co Ltd
A PHENOXI COMPOUND
JPS6013761A
(en)
*
1983-07-05
1985-01-24
Yamanouchi Pharmaceut Co Ltd
Novel pyridyl ether derivative
US4758580A
(en)
*
1985-06-26
1988-07-19
Yamanouchi Pharmaceutical Co., Ltd.
Inhibiting growth of tumors with certain substituted phenoxy dimethyl alkanoic acids, esters or salts
1986
1986-06-16
US
US06/874,547
patent/US4758580A/en
not_active
Expired – Fee Related
1986-06-20
AU
AU59128/86A
patent/AU5912886A/en
not_active
Withdrawn
1986-06-25
JP
JP61150078A
patent/JPS6289618A/en
active
Granted
1986-06-26
AU
AU59305/86A
patent/AU574926B2/en
not_active
Ceased
1986-06-26
EP
EP86304966A
patent/EP0210753A3/en
not_active
Ceased
1988
1988-05-24
US
US07/198,099
patent/US4886818A/en
not_active
Expired – Fee Related
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU604034B2
(en)
*
1986-07-24
1990-12-06
Yamanouchi Pharmaceutical Co., Ltd.
Novel phenoxy derivatives, their preparation and pharmaceutical composition containing them
Also Published As
Publication number
Publication date
EP0210753A3
(en)
1989-02-08
EP0210753A2
(en)
1987-02-04
US4886818A
(en)
1989-12-12
AU5930586A
(en)
1987-01-08
US4758580A
(en)
1988-07-19
JPS6289618A
(en)
1987-04-24
AU5912886A
(en)
1987-01-08
JPH0244810B2
(en)
1990-10-05
Similar Documents
Publication
Publication Date
Title
AU7477287A
(en)
1988-01-07
Imidazo pyridines
AU583459B2
(en)
1987-12-17
Catheter
AU7244387A
(en)
1987-11-05
Fungicidal pyridyl imidates
AU5461186A
(en)
1986-10-16
5-substituted benz-imidazole derivatives
AU1043988A
(en)
1988-07-15
Catheter
AU609036B2
(en)
1991-04-26
Fungicidal pyridine derivatives
AU4595985A
(en)
1986-02-13
Cancer treatment
AU585586B2
(en)
1989-06-22
Pyridine derivatives
AU591704B2
(en)
1989-12-14
Aryl pyridones
AU574926B2
(en)
1988-07-14
Anti-cancer treatment using imidazolyl or pyridyl alkoxyphenoxydimethylalkanoates
AU580913B2
(en)
1989-02-02
Treating laminates
AU591903B2
(en)
1989-12-21
Novel treatment
AU586742B2
(en)
1989-07-20
Adjustable steering stop
AU592586B2
(en)
1990-01-18
Pyridylalkyl substituted imidazole-2-thiols
AU8211387A
(en)
1988-06-09
Glass-fibrous laminates
AU591683B2
(en)
1989-12-14
Novel treatment
AU552800B2
(en)
1986-06-19
Safe
AU7981087A
(en)
1988-04-21
Imidazoles
AU8269787A
(en)
1988-06-23
Flyslag treatment
AU7714387A
(en)
1988-02-18
Pyridine derivatives
AU5317486A
(en)
1986-08-13
Thromboxane antagonists in the treatment of hormone-dependentneoplasias
AU584547B2
(en)
1989-05-25
Pharmaceutical “ -aminoalkyl- “ -alkylphenylacetonitriles
AU7955287A
(en)
1988-04-21
Pyridine derivatives
AU2317088A
(en)
1989-03-31
Pacemaker system
AU8004987A
(en)
1988-04-28
Safe
None